Afficher la couverture 'Identification of indole-based activators of insulin degrading enzyme | Kraupner, Nicolas' en grand format
/5

0 avis

Identification of indole-based activators of insulin degrading enzyme

Archive ouverte

Kraupner, Nicolas | Dinh, Chau Phi | Wen, Xiaoan | Landry, Valérie | Herledan, Adrien | Leroux, Florence | Bosc, Damien | Charton, Julie | Maillard, Clara | Warenghem, Sandrine | Duplan, Isabelle | Piveteau, Catherine | Hennuyer, Nathalie | Staels, Bart | Deprez, Benoit | Deprez-Poulain, Rebecca

Edité par CCSD ; Elsevier -

International audience. Insulin degrading enzyme (IDE) is a zinc metalloprotease that cleaves numerous substrates among which amyloid-β and insulin. It has been linked through genetic studies to the risk of type-2 diabetes (T2D) or Alzheimer's disease (AD). Pharmacological activation of IDE is an attractive therapeutic strategy in AD. While IDE inhibition gave paradoxal activity in glucose homeostasis, recent studies, in particular in the liver suggest that IDE activators could be also of interest in diabetes. Here we describe the discovery of an original series of IDE activators by screening and structure-activity relationships. Early cellular studies show that hit 1 decreases glucose-stimulating insulin secretion. Docking studies revealed it has an unprecedented extended binding to the polyanion-binding site of IDE. These indole-based pharmacological tools are activators of both Aβ and insulin hydrolysis by IDE and could be helpful to explore the multiple roles of IDE.

Suggestions

Du même auteur

Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice

Archive ouverte | Déprez-Poulain, Rebecca | CCSD

International audience. Insulin-degrading enzyme (IDE) is a protease that cleaves insulin and other bioactive peptides such as amyloid-β. Knockout and genetic studies have linked IDE to Alzheimer's disease and type-...

Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening

Archive ouverte | Leroux, Florence | CCSD

International audience. Insulin-degrading enzyme, IDE, is a metalloprotease implicated in the metabolism of key peptides such as insulin, glucagon, β-amyloid peptide. Recent studies have pointed out its broader role...

Structure–activity relationships of imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, dual binders of human insulin-degrading enzyme

Archive ouverte | Charton, Julie | CCSD

International audience. Insulin degrading enzyme (IDE) is a zinc metalloprotease that degrades small amyloid peptides such as amyloid-â and insulin. So far the dearth of IDE-specific pharmacological inhibitors impac...

Chargement des enrichissements...